Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
0.768
-0.017 (-2.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.752
-0.015 (-2.01%)
After-hours: Dec 5, 2025, 7:06 PM EST
Assertio Holdings Market Cap
Assertio Holdings has a market cap or net worth of $73.87 million as of December 5, 2025. Its market cap has decreased by -8.12% in one year.
Market Cap
73.87M
Enterprise Value
20.80M
1-Year Change
-8.12%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since December 1, 1998, Assertio Holdings's market cap has increased from $47.70M to $73.87M, an increase of 54.87%. That is a compound annual growth rate of 1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 75.50M | -9.25% |
| Dec 31, 2024 | 83.20M | -17.87% |
| Dec 29, 2023 | 101.30M | -51.23% |
| Dec 30, 2022 | 207.70M | 113.46% |
| Dec 31, 2021 | 97.30M | 154.05% |
| Dec 31, 2020 | 38.30M | -62.04% |
| Dec 31, 2019 | 100.90M | -56.28% |
| Dec 31, 2018 | 230.80M | -54.50% |
| Dec 29, 2017 | 507.30M | -54.28% |
| Dec 30, 2016 | 1.11B | 1.20% |
| Dec 31, 2015 | 1.10B | 15.87% |
| Dec 31, 2014 | 946.30M | 56.96% |
| Dec 31, 2013 | 602.90M | 73.60% |
| Dec 31, 2012 | 347.30M | 21.01% |
| Dec 30, 2011 | 287.00M | -14.46% |
| Dec 31, 2010 | 335.50M | 92.59% |
| Dec 31, 2009 | 174.20M | 106.89% |
| Dec 31, 2008 | 84.20M | -45.92% |
| Dec 31, 2007 | 155.70M | 7.75% |
| Dec 29, 2006 | 144.50M | -40.61% |
| Dec 30, 2005 | 243.30M | 30.04% |
| Dec 31, 2004 | 187.10M | -21.88% |
| Dec 31, 2003 | 239.50M | 627.96% |
| Dec 31, 2002 | 32.90M | -58.62% |
| Dec 31, 2001 | 79.50M | 152.38% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |